Home › NDC Lookup › Ingredients › Aripiprazole › 76483-0102-01
Aripiprazole 20 mg Tablet, Orally Disintegrating, 60-count — NDC 76483-0102-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Aripiprazole 20 mg Tablet, Orally Disintegrating, 60-count — NDC 76483-102-01 (Billing 76483-0102-01)

by SQUARE PHARMACEUTICALS LIMITED · 60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE

This is a package of 60 tablets of Aripiprazole 20 mg Tablet, Orally Disintegrating from SQUARE PHARMACEUTICALS LIMITED, marketed since Jul 2022 and currently FDA-listed.

NDC 76483-0102-01
🏷️ FDA NDC (as labeled) 76483-102-01 billing pads the product segment with a zero
This package
Contains60-count Pack sizes5 compare ↓
Also priced by: Part D plans $5.19/unit — full pricing hub ↓
Product page 76483-0102-00 Also comes in: 30 tablets 76483-102-00 30 tablets 76483-102-04 90 tablets 76483-102-02 120 tablets 76483-102-03
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Aripiprazole (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · May 27, 2026 — Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg. (Ajanta Pharma USA Inc) · FDA recall D-0594-2026
Class II · Aug 28, 2025 — Superpotent drug (Ascend Laboratories, LLC) · FDA recall D-0645-2025
Class III · Apr 9, 2024 — Cross Contamination with Other Products (Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.) · FDA recall D-0468-2024
Class III · Apr 9, 2024 — Cross Contamination with Other Products (Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.) · FDA recall D-0466-2024
Class III · Apr 9, 2024 — Cross Contamination with Other Products (Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.) · FDA recall D-0467-2024
Class III · Apr 9, 2024 — Cross Contamination with Other Products (Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.) · FDA recall D-0469-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 76483-102-01
Product NDC 76483-102
11-digit billing NDC 76483010201
RxCUI 643019, 643022, 643027, 643058
UNII 82VFR53I78
Application # ANDA090165
SPL Set ID 0f9b1fd8-a648-45c9-8655-14de07439f34
Established class (EPC) Atypical Antipsychotic
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2022-07-20
Route ORAL
Dosage form TABLET, ORALLY DISINTEGRATING
Substance ARIPIPRAZOLE
Quick answers
  • RxCUI (RxNorm): 643019
Why two NDCs? The FDA registers this code as 76483-102-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 76483-0102-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Atypical Antipsychotic class.

Pharmacologic class Atypical Antipsychotic
Drug family (ATC) Other antipsychotics
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It treats schizophrenia, bipolar I disorder, add-on treatment of major depressive disorder, irritability with autistic disorder, and Tourette's disorder. Which of these a product i...
  • Oral forms are taken by mouth once a day, with or without food. The long-acting injections are given by a healthcare professional. Follow your prescriber's directions.
  • Common ones include nausea, headache, dizziness, restlessness, trouble sleeping and sleepiness. Tell your doctor if they bother you.
  • Call right away for fever with stiff muscles or confusion, uncontrolled movements, fainting, seizures, new gambling urges, or worsening mood or suicidal thoughts.
📖 Read our full Aripiprazole guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $5.19 $311.37 / 60 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
76483-0102-00 76483-102-00 Main listing 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE 2022-07-20 — Active
76483-0102-01 You're viewing this 60 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE 2022-07-20 — Active
76483-0102-02 76483-102-02 90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE 2022-07-20 — Active
76483-0102-03 76483-102-03 120 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE 2022-07-20 — Active
76483-0102-04 76483-102-04 30 TABLET, ORALLY DISINTEGRATING in 1 CARTON 2023-02-22 — Active

Pack size FAQ

What quantity is in this package?
This is a 60-count package — 60 tablet, orally disintegrating in 1 bottle.
How does this package differ from NDC 76483-0102-00?
Both are Aripiprazole 20 mg Tablet, Orally Disintegrating — the drug itself is identical. This page's package is the 60-count one, while NDC 76483-0102-00 is the 30 tablets package.
What NDC number is used to bill for this package of Aripiprazole 20 mg Tablet, Orally Disintegrating?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Aripiprazole 20 mgthis 76483-0102-01 SQUARE 60 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2022
On the market since
Jul 2022
📍
2026
Currently FDA-listed
4 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color White
ShapeRound
ImprintZF;44
Size1 mm
ScoringNot scored
FlavorPeppermint
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII Z0H242BBR1
    Aspartame is an artificial sweetener made from amino acids. It's added to medicines to improve taste, making bitter or unpleasant-tasting drugs easier to take.
  • UNII 776XM7047L
    Calcium stearate is a white powder derived from stearic acid and calcium. It works as a lubricant and glidant to help the medicine flow smoothly during manufacturing and prevent ingredients from sticking to equipment.
  • UNII 2S7830E561
    Crospovidone is a synthetic polymer derived from povidone. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the active ingredient can be absorbed.
  • UNII 3OWL53L36A
    A natural sugar alcohol derived from seaweed or synthesized in the lab. It's used as a filler to add bulk, a sweetener in sugar-free formulas, and a disintegrant to help tablets break apart in the stomach.
  • UNII V95R5KMY2B
    Peppermint is a flavoring agent derived from the peppermint plant. It's added to medicines to improve taste and mask bitter or unpleasant flavors, making them easier to take.

5 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerSQUARE PHARMACEUTICALS LIMITED
Application holderSQUARE PHARMACEUTICALS LTD
FDA applicationANDA090165 (ANDA)
Labeler code76483
First marketedJul 2022
Product typeHuman Prescription Drug
Portfolio14 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 Package Label / Principal Display Panel
📄 Package Label / Principal Display Panel ~2 min read ▾

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 76483-100-00 Aripiprazole Orally Disintegrating Tablets, USP 10 mg 30 Tablets Rx Only NDC 76483-100-01 Aripiprazole Orally Disintegrating Tablets, USP 10 mg 60 Tablets Rx Only NDC 76483-100-02 Aripiprazole Orally Disintegrating Tablets, USP 10 mg 90 Tablets Rx Only NDC 76483-100-03 Aripiprazole Orally Disintegrating Tablets, USP 10 mg 120 Tablets Rx Only NDC 76483-101-00 Aripiprazole Orally Disintegrating Tablets, USP 15 mg 30 Tablets Rx Only NDC 76483-101-01 Aripiprazole Orally Disintegrating Tablets, USP 15 mg 60 Tablets Rx Only NDC 76483-101-02 Aripiprazole Orally Disintegrating Tablets, USP 15 mg 90 Tablets Rx Only NDC 76483-101-03 Aripiprazole Orally Disintegrating Tablets, USP 15 mg 120 Tablets Rx Only NDC 76483-102-00 Aripiprazole Orally Disintegrating Tablets, USP 20 mg 30 Tablets Rx Only NDC 76483-102-01 Aripiprazole Orally Disintegrating Tablets, USP 20 mg 60 Tablets Rx Only NDC 76483-102-02 Aripiprazole Orally Disintegrating Tablets, USP 20 mg 90 Tablets Rx Only NDC 76483-102-03 Aripiprazole Orally Disintegrating Tablets, USP 20 mg 120 Tablets Rx Only NDC 76483-103-00 Aripiprazole Orally Disintegrating Tablets, USP 30 mg 30 Tablets Rx Only NDC 76483-103-01 Aripiprazole Orally Disintegrating Tablets, USP 30 mg 60 Tablets Rx Only NDC 76483-103-02 Aripiprazole Orally Disintegrating Tablets, USP 30 mg 90 Tablets Rx Only NDC 76483-103-03 Aripiprazole Orally Disintegrating Tablets, USP 30 mg 120 Tablets Rx Only Aripiprazole Orally Disintegrating Tablets 10 mg (30 Tablets in 1 Carton) Each orally disintegrating tablet contains 10 mg aripiprazole USP NDC 76483-100-04 Rx Only Aripiprazole Orally Disintegrating Tablets 15 mg (30 Tablets in 1 Carton) Each orally disintegrating tablet contains 15 mg aripiprazole USP NDC 76483-101-04 Rx Only Aripiprazole Orally Disintegrating Tablets, 20 mg (30 Tablets in 1 Carton) Each orally disintegrating tablet contains 20 mg aripiprazole USP NDC 76483-102-04 Rx Only Aripiprazole Orally Disintegrating Tablets 30 mg (30 Tablets in 1 Carton) Each orally disintegrating tablet contains 30 mg aripiprazole USP NDC 76483-103-04 Rx Only Aripiprazole Orally Disintegrating Tablets, USP 10 mg; 30 counts Aripiprazole Orally Disintegrating Tablets, USP 10 mg; 60 Counts Aripiprazole Orally Disintegrating Tablets, USP 10 mg; 90 Counts Aripiprazole Orally Disintegrating Tablets, USP 10 mg; 120 Counts Aripiprazole Orally Disintegrating Tablets, USP 15 mg; 30 Counts Aripiprazole Orally Disintegrating Tablets, USP 15 mg; 60 Counts Aripiprazole Orally Disintegrating Tablets, USP 15 mg; 90 Counts Aripiprazole Orally Disintegrating Tablets, USP 15 mg; 120 Counts 20-30 Aripiprazole Orally Disintegrating Tablets, USP 20 mg; 60 Counts Aripiprazole Orally Disintegrating Tablets, USP 20 mg; 90 Counts Aripiprazole Orally Disintegrating Tablets, USP 20 mg; 120 Counts Aripiprazole Orally Disintegrating Tablets, USP 30 mg; 30 Counts Aripiprazole Orally Disintegrating Tablets, USP 30 mg; 60 Counts Aripiprazole Orally Disintegrating Tablets, USP 30 mg; 90 Counts Aripiprazole Orally Disintegrating Tablets, USP 30 mg; 120 Counts Aripiprazole Orally Disintegrating Tablets, 10 mg (30 Tablets in 1 Carton) Aripiprazole Orally Disintegrating Tablets, 15 mg (30 Tablets in 1 Carton) Aripiprazole Orally Disintegrating Tablets 20 mg (30 Tablets in 1 Carton) Aripiprazole Orally Disintegrating Tablets, 30 mg (30 Tablets in 1 Carton)

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Aripiprazole — the program that covers self-administered drugs. 20 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Aripiprazole. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$46.18M
Claims incl. refills
1M
Beneficiaries
482.8K
Spend / beneficiary
$95.64
Spend / claim
$45.64
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by SQUARE PHARMACEUTICALS LIMITED. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 4 other package presentations of this same product, including 30 tablets (76483-0102-00), 30 tablets (76483-0102-04), 90 tablets (76483-0102-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
SQUARE PHARMACEUTICALS LIMITED is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 76483-0101-00 · SQUARE 76483-0103-00 · SQUARE →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.